Total planned funding: $1,879,149,749
Clear active filters
Nigeria
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $1,879,149,749 |
Organizational Types
Private Contractor | $484,981,242 |
Unknown | $380,141,012 |
NGO | $365,867,108 |
University | $236,428,899 |
Implementing Agency | $145,550,827 |
Own Agency | $143,835,206 |
FBO | $104,811,060 |
Other USG Agency | $10,284,395 |
Host Country Government Agency | $6,750,000 |
Multi-lateral Agency | $500,000 |
Program Areas
Treatment | $713,166,919 |
Care | $425,152,464 |
Governance and Systems | $293,632,388 |
Prevention | $267,414,029 |
Management and Operations | $110,071,166 |
Testing | $69,712,783 |
Budget Codes
HTXD: Treatment: ARV Drugs | $390,600,886 |
HTXS: Treatment: Adult Treatment | $299,529,428 |
HKID: Care: Orphans and Vulnerable Children | $196,559,597 |
HBHC: Care: Adult Care and Support | $153,198,520 |
HLAB: Laboratory Infrastructure | $123,751,911 |
HVMS: Management and Operations | $110,071,166 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $105,743,206 |
OHSS: Health Systems Strengthening | $89,827,763 |
HVSI: Strategic Information | $80,052,714 |
HVOP: Sexual Prevention: Other Sexual Prevention | $71,868,909 |
HVCT: Testing: HIV Testing and Counseling | $69,712,783 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $56,350,871 |
HVTB: Care: TB/HIV | $53,839,776 |
PDTX: Treatment: Pediatric Treatment | $23,036,605 |
HMBL: Biomedical Prevention: Blood Safety | $21,802,570 |
PDCS: Care: Pediatric Care and Support | $21,554,571 |
HMIN: Biomedical Prevention: Injection Safety | $11,648,473 |
Top Partner Programs
Not Available:
$337,133,313
Countries/Regions
Chemonics International:
$232,758,052
Countries/Regions
FHI 360:
$145,488,598
Countries/Regions
USG Aggregated Agencies:
$105,628,267
Countries/Regions